#my_4_slides search results

This year I am late in #my_4_slides on my most important takeaways from #CTO2025 Lots of great stuff and I will start with the intriguing #CTO #PCI techniques I will try in 2025. 1-HDR presentation by @realarainmd He explains it perfectly, his cases on X are enjoyable. In a…

#my_4_slides from Sensei Satoru Sumitsuji on perforations and optimal coiling at #CTO2024 Not too proximal or too far, and not on the opposite side of flow. With retrograde channel perf and non-opened CTO, weak antegrade flow might save you if you can't coil the other side!

#my_4_slides from the exciting surgical #endarterectomy piece by John Sukas at #CTO2024 End-stage recurrent ISR- stentectomy and endarterectomy with durable results at 12 months. Makes me think, can we do this percutaneously, or is it too early #cardiotwitter #ACCFIT

#my_4_slides from @LAzzaliniMD on "what happened in #CHIP #PCI last year" at the #CTO2024 Explanations of the slides are in the thread below #cardiotwitter #ACCFIT 1/5

My favorite #my_4_slides from @RhianEDavies1 "What happened in #CTO #PCI last year" Explanations of the slides are in the thread below #CTO2024 #cardiotwitter #ACCFIT 1/5

#My_4_slides on the best tricks I learned this year at #CTO2023 #CTOplus A concept mentioned by @JTiwanaMD on choosing microcatheters in #ECART according to insulation properties. Lit search showed the most consistent success was Finecross! Appreciate input from experts! 1/4

Schumacher et al. show that prognosis will improve in LV dysfunction with #CTO #PCI only if we reduce ischemia! A simple concept, but it confirms and adds to what we understand #my_4_slides #cardiotwitter #CTO2023 #CTOplus 3/4

#my_4_slides #CTO2023 Most important studies on #CTO #CHIP last year #OPTIMUM Multivessel #PCI in surgical turndown patients/ improved QOL. Realistic expectation of 3% in hospital and 5.6% 30-day mortality! We still need to do better with complete revasc!(rSSS<8% only 34%) 1/4

#my_4_slides from @jcspratt lecture at #TCT2022 explaining the concept of vessel compliance. A concept that every IC should be familiar with, especially #CTO #PCI operators who use the SI space as their ally #cardiotwitter #ACCFIT

My favorite #my_4_slides on #LM revascularization from #TCT2022 by Jose De la Torre Hernandez highlighting -Excel criteria for post-LM stenting are 6,7, and 10 mm2 -IVUS criteria of LCX disease (layered plaque, calcified nodule, MLA <4 mm2) #cardiotwitter #ACCFIT

Impressive talk by @AGoldsweig explaining the impossible to understand. How healthcare is regulated in US! A very important piece where @SCAI is an advocate for all interventionalists #scai2022 #cardiotwitter #my_4_slides

#my_4_slides on #MCS in high-risk #PCI and Complete Revasc from #CTO2022 Understand your risk and be ready for it. #CTO is a major cause of incomplete revasc, so complete but also consider optimal revasc tailored to patients' needs #Cardiotwitter #MedED #ACCFIT #ACCIC #CardioED

#My_4_slides on #CTO #PCI #complications from #CTOconnect #CTO2021 by @RajaHatem , Anja Oksnes, and Ellit Smith #Cardiotwitter #CardioED #Medtwitter #MedED #PCIcase #CTO101 @crfheart

#My_4_slides on #Retrograde #CTO #PCI @KambisMashayek1 Dr. Kao, and @RhianEDavies1 #CTOconnect #Cto2021 #Cardiotwitter #CardioED #Medtwitter #MedED #PCIcase #CTO101 @crfheart

#My_4_slides on #AFR (Antegrade Fenestration Reenter) as a new #ADR technique for #CTO #PCI by @lorenzo2509 and @MauroCarlino3 #CTOconnect #Cto2021 #Cardiotwitter #CardioED #Medtwitter #MedED #PCIcase #CTO101 @AshishPershad @ajaykirtane @DrJMHill @jstrange1

#My_4_slides on #IVUS guided #AWE with #CTO #PCI by Masters Dr. Satoru Sumitsuji and Dr. Masahisa Yamane #CTOconnect #Cto2021 #Cardiotwitter #CardioED #Medtwitter #MedED #PCIcase #CTO101 @jcspratt @perc_surgeon @ArasiMaran @RobertoGarbo1

#My_4_slides on #Retrograde #CTO #PCI @KambisMashayek1 Dr. Kao, and @RhianEDavies1 #CTOconnect #Cto2021 #Cardiotwitter #CardioED #Medtwitter #MedED #PCIcase #CTO101 @crfheart

#My_4_slides on #AFR (Antegrade Fenestration Reenter) as a new #ADR technique for #CTO #PCI by @lorenzo2509 and @MauroCarlino3 #CTOconnect #Cto2021 #Cardiotwitter #CardioED #Medtwitter #MedED #PCIcase #CTO101 @AshishPershad @ajaykirtane @DrJMHill @jstrange1

#My_4_slides on #CTO #PCI #complications from #CTOconnect #CTO2021 by @RajaHatem , Anja Oksnes, and Ellit Smith #Cardiotwitter #CardioED #Medtwitter #MedED #PCIcase #CTO101 @crfheart

#My_4_slides on #CTO #PCI literature updates in 2020 from #CTOconnect #CTO2021 by @DrDarshanDoshi @jcspratt @DKarmpaliotis @SanjogKalra Renato Valenti, David Antoniucci, @YbarraLuiz @RinfretStephane #Cardiotwitter #CardioED #Medtwitter #MedED #PCIcase #CTO101 @crfheart

#My_4_slides on #IVUS guided #AWE with #CTO #PCI by Masters Dr. Satoru Sumitsuji and Dr. Masahisa Yamane #CTOconnect #Cto2021 #Cardiotwitter #CardioED #Medtwitter #MedED #PCIcase #CTO101 @jcspratt @perc_surgeon @ArasiMaran @RobertoGarbo1

#My_4_slides on the best tricks I learned this year at #CTO2023 #CTOplus A concept mentioned by @JTiwanaMD on choosing microcatheters in #ECART according to insulation properties. Lit search showed the most consistent success was Finecross! Appreciate input from experts! 1/4

#my_4_slides from @jcspratt lecture at #TCT2022 explaining the concept of vessel compliance. A concept that every IC should be familiar with, especially #CTO #PCI operators who use the SI space as their ally #cardiotwitter #ACCFIT

#my_4_slides on #MCS in high-risk #PCI and Complete Revasc from #CTO2022 Understand your risk and be ready for it. #CTO is a major cause of incomplete revasc, so complete but also consider optimal revasc tailored to patients' needs #Cardiotwitter #MedED #ACCFIT #ACCIC #CardioED

This year I am late in #my_4_slides on my most important takeaways from #CTO2025 Lots of great stuff and I will start with the intriguing #CTO #PCI techniques I will try in 2025. 1-HDR presentation by @realarainmd He explains it perfectly, his cases on X are enjoyable. In a…

My favorite #my_4_slides on #LM revascularization from #TCT2022 by Jose De la Torre Hernandez highlighting -Excel criteria for post-LM stenting are 6,7, and 10 mm2 -IVUS criteria of LCX disease (layered plaque, calcified nodule, MLA <4 mm2) #cardiotwitter #ACCFIT

My favorite #my_4_slides from @RhianEDavies1 "What happened in #CTO #PCI last year" Explanations of the slides are in the thread below #CTO2024 #cardiotwitter #ACCFIT 1/5

#my_4_slides from @LAzzaliniMD on "what happened in #CHIP #PCI last year" at the #CTO2024 Explanations of the slides are in the thread below #cardiotwitter #ACCFIT 1/5

#my_4_slides #CTO2023 Most important studies on #CTO #CHIP last year #OPTIMUM Multivessel #PCI in surgical turndown patients/ improved QOL. Realistic expectation of 3% in hospital and 5.6% 30-day mortality! We still need to do better with complete revasc!(rSSS<8% only 34%) 1/4

Impressive talk by @AGoldsweig explaining the impossible to understand. How healthcare is regulated in US! A very important piece where @SCAI is an advocate for all interventionalists #scai2022 #cardiotwitter #my_4_slides

#my_4_slides from Sensei Satoru Sumitsuji on perforations and optimal coiling at #CTO2024 Not too proximal or too far, and not on the opposite side of flow. With retrograde channel perf and non-opened CTO, weak antegrade flow might save you if you can't coil the other side!

Schumacher et al. show that prognosis will improve in LV dysfunction with #CTO #PCI only if we reduce ischemia! A simple concept, but it confirms and adds to what we understand #my_4_slides #cardiotwitter #CTO2023 #CTOplus 3/4

#my_4_slides from the exciting surgical #endarterectomy piece by John Sukas at #CTO2024 End-stage recurrent ISR- stentectomy and endarterectomy with durable results at 12 months. Makes me think, can we do this percutaneously, or is it too early #cardiotwitter #ACCFIT